Publications

Purchase

November 2024
Background Note

Social Enterprise in the MENA Region

By: Brian Trelstad and Ahmed Dahawy

This research note provides an overview of the socio-economic landscape of social enterprise in the Middle East and North Africa. It highlights the diversity of players in the region including social enterprise organizations (in their many forms) and supporting... View Details

Article

Biosimilars and Follow-On Products in the United States: Adoption, Prices, and Users

By: Ariel Dora Stern, Jacqueline L. Chen, Melissa Ouellet, Mark R. Trusheim, Zeid El-Kilani, Amber Jessup and Ernst R. Berndt

Biologic drugs account for a disproportionate share of the increase in pharmaceutical spending in the U.S. and worldwide. Against this backdrop, many look to the expanding market for biosimilars—follow-on products to biologic drugs—as a vehicle for controlling... View Details

Keywords: Pharmaceuticals; Drug Spending; Drug Pricing; Health Care and Treatment; Spending; Price; Markets; Cost Management; United States

Article

Time-Driven Activity-Based Costing in Emergency Medicine

By: Robert S. Kaplan, Brian J. Yun, Anand M. Prabhakar, Jonathan Warsh, John Brennan, Kyle E. Dempsey and Ali S. Raja

Value in emergency medicine is determined by both patient-important outcomes and the costs associated with achieving them. However, measuring true costs is challenging. Without an understanding of costs, emergency department (ED) leaders will be unable to determine... View Details

Keywords: Time-Driven Activity-Based Costing; Emergency Room; Health Care and Treatment; Value; Cost Management; Activity Based Costing and Management

19 Dec 2023
Research & Ideas

15 Podcast Episodes That Grabbed Listeners in 2023

to innovate in the climate space, and shares his advice for those interested in careers in business and climate. Beyond Net Zero: How Seventh Generation Plans to Achieve Real... View Details

Keywords: by Danielle Kost

12 Feb 2020
News

Introducing the HCI “Health Minute”

2022
Working Paper

Causal Inference During A Pandemic: Evidence on the Effectiveness of Nebulized Ibuprofen as an Unproven Treatment for COVID-19 in Argentina

By: Sebastian Calonico, Rafael Di Tella and Juan Cruz Lopez Del Valle

Many medical decisions during the pandemic were made without the support of causal evidence obtained in clinical trials. We study the case of nebulized ibuprofen (NaIHS), a drug that was extensively used on COVID-19 patients in Argentina amidst wild claims about its... View Details

Keywords: COVID-19; Drug Treatment; Health Pandemics; Health Care and Treatment; Decision Making; Outcome or Result; Argentina

Find at Harvard

20 Jan 2021
News

In Conversation with Stéphane Bancel

Article

Practicing Medicine in the Age of Facebook

In my second week of medical internship, I received a "friend request" on Facebook, the popular social-networking Web site. The name of the requester was familiar: Erica Baxter. Three years earlier, as a medical student, I had participated in the delivery of Ms.... View Details

Keywords: Ethics; Relationships; Health Care and Treatment; Health Industry

April 2017
Case

China Hospitals Inc.: The Growth of Private Hospitals in China

By: Kevin Schulman, Xiao Yu and Ariel Hwang

This case examines the privatization of hospitals in China. China Hospitals, Inc. has become the largest for-profit hospital company in China, purchasing government owned hospitals in Tier 2 cities. The case profiles CEO Frank Hu. To build his company, he has to... View Details

Keywords: Privatization; For-Profit Firms; Growth and Development Strategy; Business Model; Health Industry; China

Purchase

Web

In The Community | About

to the public Harvard Innovation Labs The Harvard Innovation Labs provide a multitude of in-kind support for local entrepreneurship, health and life sciences, and offer a variety of partner programming and mentorships. View Details

09 Jun 2021
News

Biden To Announce Plans To Donate 500 Million Pfizer Vaccines To Countries In Need

May 2021 (Revised May 2022)
Case

Headspace vs. Calm: A Mindful Competition

By: Ayelet Israeli and Anne Wilson

By 2021, the mindfulness app wars reached their apex. Over 2,000 meditation apps were available to consumers, but two apps, Headspace and Calm, dominated the space, jointly holding about 70% of the total market. Headspace had established itself as the approachable... View Details

Keywords: Marketing Communication; Integrated Strategy; Brand; Brand ＆ Product Management; Brand Communication; Brand Differentiation; Brand Building; Brand Management; E-Commerce Strategy; Ecommerce; App; App Development; Applications; COVID; COVID-19; Pandemic; Pricing; Pricing Strategy; Subscription Model; Subscription; Partnerships; Strategic Partnerships; B2B Vs. B2C; B2B; Health ＆ Wellness; Wellbeing; Digitization; Commoditization; Mobile App; Mobile App Industry; Mobile Healthcare; Mobile Marketing; Digital Brand; Digital Health; Consumer Health; Apps; Online Business; Online Competition; Online Community; Online Entertainment; Entertainment And Leisure; Meditation; Marketing; Marketing Communications; Brands and Branding; Price; Strategy; Competition; Competitive Strategy; Competitive Advantage; Partners and Partnerships; Health; Well-being; Mobile and Wireless Technology; Communication; Communication Strategy; Disruption; Consumer Behavior; Digital Marketing; E-commerce; Applications and Software; Health Industry; Health Industry; Health Industry; United States; North America; United Kingdom

Purchase

2022
Article

The Great Resignation Didn't Start with the Pandemic

By: Joseph B. Fuller and William R. Kerr

COVID-19 spurred on the Great Resignation of 2021, during which record numbers of employees voluntarily quit their jobs. But what we are living through is not just short-term turbulence provoked by the pandemic. Instead, it’s the continuation of a trend of rising quit... View Details

Keywords: Quit Rate; Labor Market; Great Resignation; Jobs and Positions; Employees; Resignation and Termination; Health Pandemics

August 2024
Case

Sky Therapeutics: Innovating in Digital Therapeutics

By: Satish Tadikonda, Olivia Reszczynski and William Marks

Shad Faraz and Alex Youssef were intrigued by the opportunities in the relatively new area of Digital Therapeutics. Despite initial successes, early entrants had struggled with reimbursement and revenue-predictability challenges. However, venture investors still... View Details

Keywords: Business Startups; Entrepreneurship; Mission and Purpose; Health Care and Treatment; Technological Innovation; Business Strategy; Health Industry; Health Industry

28 Apr 2021
News

Psychological Safety in a Hybrid World

2010
Chapter

New Sources in Living Kidney Donation

By: Ruthanne L. Hanto, Alvin E. Roth, M. Utku Ünver and Francis L. Delmonico

Keywords: Health Care and Treatment; Philanthropy and Charitable Giving; Health Industry

Summer 2014
Article

Designed for Workarounds: A Qualitative Study of the Causes of Operational Failures in Hospitals

By: Anita L. Tucker, W. Scott Heisler and Laura D. Janisse

Frontline care providers in hospitals spend at least 10% of their time working around operational failures, which are situations where information, supplies, or equipment needed for patient care are insufficient. However, little is known about underlying causes of... View Details

Keywords: Supply Chain; Health Care and Treatment; Failure; Business Processes; Health Industry

October 2024
Case

Allurion: Competing in the Age of GLP-1

By: Satish Tadikonda, Rajiv Lal, David Lane and Sarah Sasso

Shantanu Gaur had built Allurion into a formidable business internationally, providing obesity patients with a less invasive option long before GLP-1 drugs became the latest craze. Selling Allurion's medical device across 60+ countries, he awaited FDA approval to bring... View Details

Keywords: Corporate Entrepreneurship; Health Care and Treatment; Global Strategy; Competitive Strategy; Market Entry and Exit; Health Industry; Health Industry; United States; United Kingdom; France; India; Brazil; Middle East